1. Home
  2. PNTG vs NNNN Comparison

PNTG vs NNNN Comparison

Compare PNTG & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PNTG
  • NNNN
  • Stock Information
  • Founded
  • PNTG 2019
  • NNNN 2021
  • Country
  • PNTG United States
  • NNNN Germany
  • Employees
  • PNTG N/A
  • NNNN N/A
  • Industry
  • PNTG Medical/Nursing Services
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • PNTG Health Care
  • NNNN Health Care
  • Exchange
  • PNTG Nasdaq
  • NNNN Nasdaq
  • Market Cap
  • PNTG 805.7M
  • NNNN 267.7M
  • IPO Year
  • PNTG N/A
  • NNNN 2025
  • Fundamental
  • Price
  • PNTG $28.17
  • NNNN $6.63
  • Analyst Decision
  • PNTG Buy
  • NNNN
  • Analyst Count
  • PNTG 5
  • NNNN 0
  • Target Price
  • PNTG $35.80
  • NNNN N/A
  • AVG Volume (30 Days)
  • PNTG 183.8K
  • NNNN 32.8K
  • Earning Date
  • PNTG 05-06-2025
  • NNNN 01-01-0001
  • Dividend Yield
  • PNTG N/A
  • NNNN N/A
  • EPS Growth
  • PNTG 40.99
  • NNNN N/A
  • EPS
  • PNTG 0.76
  • NNNN 0.06
  • Revenue
  • PNTG $748,167,000.00
  • NNNN $8,185,146.00
  • Revenue This Year
  • PNTG $22.27
  • NNNN N/A
  • Revenue Next Year
  • PNTG $7.38
  • NNNN N/A
  • P/E Ratio
  • PNTG $36.89
  • NNNN $116.38
  • Revenue Growth
  • PNTG 30.04
  • NNNN 21.95
  • 52 Week Low
  • PNTG $21.18
  • NNNN $5.18
  • 52 Week High
  • PNTG $37.13
  • NNNN $7.82
  • Technical
  • Relative Strength Index (RSI)
  • PNTG 71.13
  • NNNN N/A
  • Support Level
  • PNTG $25.05
  • NNNN N/A
  • Resistance Level
  • PNTG $27.18
  • NNNN N/A
  • Average True Range (ATR)
  • PNTG 1.07
  • NNNN 0.00
  • MACD
  • PNTG 0.24
  • NNNN 0.00
  • Stochastic Oscillator
  • PNTG 86.24
  • NNNN 0.00

About PNTG The Pennant Group Inc.

Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: